Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 152-53-4 | MDL No. : | MFCD00035308 |
Formula : | C11H15Cl2N5 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | MOUAPRKJJUXEIE-UHFFFAOYSA-N |
M.W : | 288.18 | Pubchem ID : | 9048 |
Synonyms : |
Cycloguanil (hydrochloride);Cycloguanil hydrochloride;NSC 3074;Chloroguanide Triazine
|
Num. heavy atoms : | 18 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.27 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 87.34 |
TPSA : | 80.0 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | Yes |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.76 cm/s |
Log Po/w (iLOGP) : | 0.0 |
Log Po/w (XLOGP3) : | 1.83 |
Log Po/w (WLOGP) : | 1.19 |
Log Po/w (MLOGP) : | 2.25 |
Log Po/w (SILICOS-IT) : | 1.67 |
Consensus Log Po/w : | 1.39 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.96 |
Solubility : | 0.316 mg/ml ; 0.0011 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.13 |
Solubility : | 0.214 mg/ml ; 0.000741 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.3 |
Solubility : | 0.145 mg/ml ; 0.000505 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 0.0 |
Synthetic accessibility : | 3.34 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
A666468[ 516-21-2 ]
1-(4-Chlorophenyl)-6,6-dimethyl-1,6-dihydro-1,3,5-triazine-2,4-diamine
Reason: Free-salt
[ 2113-05-5 ]
1-(3-Chlorophenyl)biguanide hydrochloride
Similarity: 0.62
[ 56-95-1 ]
1,1'-Hexamethylenebis[5-(p-chlorophenyl)biguanide] diacetate
Similarity: 0.56
[ 14088-98-3 ]
1-(3-Chlorophenyl)imidazolidin-2-one
Similarity: 0.54
[ 2113-05-5 ]
1-(3-Chlorophenyl)biguanide hydrochloride
Similarity: 0.62
[ 18672-03-2 ]
5,6-Dichloro-1H-benzo[d]imidazol-2-amine
Similarity: 0.60
[ 56-95-1 ]
1,1'-Hexamethylenebis[5-(p-chlorophenyl)biguanide] diacetate
Similarity: 0.56
[ 14088-98-3 ]
1-(3-Chlorophenyl)imidazolidin-2-one
Similarity: 0.54
[ 2113-05-5 ]
1-(3-Chlorophenyl)biguanide hydrochloride
Similarity: 0.62
[ 90871-47-9 ]
2-Amino-1-isopropylbenzimidazole
Similarity: 0.61
[ 18672-03-2 ]
5,6-Dichloro-1H-benzo[d]imidazol-2-amine
Similarity: 0.60
[ 57667-50-2 ]
1-Propyl-1H-benzo[d]imidazol-2-amine
Similarity: 0.57
[ 56-95-1 ]
1,1'-Hexamethylenebis[5-(p-chlorophenyl)biguanide] diacetate
Similarity: 0.56